Episodes
-
Welcome to the eight episode of Health Econ on the Go. In this episode, we will cover three papers from August 2024, reflecting on energy poverty effects on an aging population, review a combined medical-microfinance intervention for managing hypertension in Kenya, and take a look into how AI-based technology is being evaluated for breast cancer screening in the UK. We launched this podcast with the moto "finish not perfect", so please leave me your comments and questions at [email protected]
Sign petition here!: https://www.kickbigsodaout.org/
Papers discussed on this episode:
Calls for the Olympics to end harmful Coca-Cola sponsorship: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)01638-6/abstract"The impact of energy poverty on the health and welfare of the middle-aged and older adults” available here: https://www.frontiersin.org/journals/publichealth/articles/10.3389/fpubh.2024.1404014/full"Cost-effectiveness of group medical visits and microfinance interventions versus usual care to manage hypertension in Kenya" available here: https://www.thelancet.com/action/showPdf?pii=S2214-109X%2824%2900188-8"Cost-Effectiveness of AI for Risk-Stratified Breast Cancer Screening” available here: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/282325"Limitarianism" Goodreads link (follow-up from last episode): https://www.goodreads.com/book/show/141310682-limitarianismThis Podcast Will Kill You: https://thispodcastwillkillyou.com/ -
Welcome to the special summer episode of Health Econ On The Go. In this episode, we will cover four papers from June and July 2024, touching on women's health, from breast cancer treatment to postpartum haemorrhage, tobacco control and the sale revenues of new drugs. We launched this podcast with the moto "finish not perfect", so please leave me your comments and questions at [email protected]
Papers discussed on this episode:
Global Health Now: https://globalhealthnow.org"Cost of illness of breast cancer in low- and middle-income countries: a systematic review": https://healtheconomicsreview.biomedcentral.com/articles/10.1186/s13561-024-00536-0"Crowding out and impoverishing effect of tobacco in Mexico" available here: https://pubmed.ncbi.nlm.nih.gov/37567601/"Crowding-out effect of tobacco consumption in Serbia" available here: https://tobaccocontrol.bmj.com/content/tobaccocontrol/early/2023/03/28/tc-2022-057727.full.pdf"A cost-effectiveness analysis of early detection and bundled treatment of postpartum hemorrhage alongside the E-MOTIVE trial" available here: https://www.nature.com/articles/s41591-024-03069-5"Sales Revenues for New Therapeutic Agents Approved by the United States Food and Drug Administration From 1995 to 2014" available here: https://www.valueinhealthjournal.com/article/S1098-3015(24)02754-2/fulltext"Limitarianism" Goodreads link: https://www.goodreads.com/book/show/141310682-limitarianism -
Missing episodes?
-
Welcome to the sixth episode of Health Econ On The Go. In this episode, we will cover three papers from May 2024, touching on the economic impact of One Health interventions, the effects of industry gifts to physicians and the different strategies to increase plasma donation. We launched this podcast with the moto "finish not perfect", so please leave me your comments and questions at [email protected]
Papers discussed on this episode:
"The Impact of Global Health R&D: The high return of investing in R&D for neglected diseases" https://d110txtih22jhy.cloudfront.net/The%20Impact%20of%20Global%20Health%20R&D%20Report.pdf"This is the world’s best investment: A new study finds that combating malaria, TB, and HIV pays for itself 405 times over." https://www.vox.com/today-explained-newsletter/352605/global-health-investment-study-roi"Current evidence of the economic value of One Health initiatives: A systematic literature review" available here: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11103946/"The cost of influence: How gifts to physicians shape prescriptions and drug costs" available here: https://www.sciencedirect.com/science/article/pii/S0167629624000328?ref=pdf_download&fr=RR-2&rr=88f914ec0924b762"Incentives for plasma donation" available here: https://onlinelibrary.wiley.com/doi/10.1111/vox.13644"Lifelines: A Doctor's Journey in the Fight for Public Health" Goodreads link: https://www.goodreads.com/book/show/55077565-lifelines -
Welcome to the fifth episode of Health Econ On The Go. In this episode, we will cover three papers from April 2024, touching on the impact of willingness-to-pay thresholds on access to cancer drugs, a review of the pay-for-performance scheme in Brazil and an analysis of the relationship between welfare generosity and health. We launched this podcast with the moto "finish not perfect", so please leave me your comments and questions at [email protected]
Papers discussed on this episode:
"The impact of willingness-to-pay threshold on price reduction recommendations for oncology drugs: a review of assessments conducted by the Canadian Agency for Drugs and Technologies in Health", available here: https://becarispublishing.com/doi/full/10.57264/cer-2023-0178"Does pay-for-performance design matter? Evidence from Brazil" available here: https://pubmed.ncbi.nlm.nih.gov/38661300/#:~:text=The%20cluster%20analysis%20showed%20what,in%20the%20mean%20PMAQ%20score."Is Redistribution Good for Our Health? Examining the Macro-Correlation between Welfare Generosity and Health across EU Nations over the Last 40 Years" available here: https://pubmed.ncbi.nlm.nih.gov/38567772/The suggested movie is "Dark Waters" (https://www.imdb.com/title/tt9071322/)
-
Welcome to the fourth episode of Health Econ On The Go. In this episode, we will cover three papers from March 2024, discussing financial incentives for integrated care, wellbeing improvements as a novel outcome measure in health, and the rising costs of oncology drugs in Canada. We launched this podcast with the moto "finish not perfect", so please leave me your comments and questions at [email protected]
Papers discussed on this episode:
“A QALY is [still] a QALY is [still] a QALY?” available here: https://bmcmedethics.biomedcentral.com/articles/10.1186/s12910-024-01036-w“Financial incentives for integrated care: A scoping review and lessons for evidence-based design” available here: https://pubmed.ncbi.nlm.nih.gov/38290390/“From Health to Wellbeing: Toward a Monetary Valuation of a Wellbeing-Adjusted Life-Year“ available here: https://www.valueinhealthjournal.com/article/S1098-3015(24)00087-1/fulltext”“Cost and value of cancer medicines in a single-payer public health system in Ontario, Canada: a cross-sectional study“ available here: https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(24)00072-X/abstractSedated: How Modern Capitalism Created our Mental Health Crisis – Book review available here: https://www.goodreads.com/en/book/show/57751566
-
Welcome to the third episode of Health Econ On The Go. In this episode, we will cover three papers from February 2024, touching on the cost-effectiveness of an early parenting programme, the cost-effectiveness of malaria vaccination and a review of the impact of economic policies on hypertension management. We launched this podcast with the moto "finish not perfect", so please leave me your comments and questions at [email protected]
Papers discussed on this episode:
"Why are our medicines so expensive? Spoiler: Not for the reasons you are being told…" available here: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10836477/"A cost-effectiveness analysis of a universal, preventative-focused, parent and infant programme" available here: https://bmchealthservres.biomedcentral.com/articles/10.1186/s12913-023-10492-w"The public health impact and cost-effectiveness of the R21/Matrix-M malaria vaccine: a mathematical modelling study " available here: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00816-2/fulltext"Association of Economic Policies With Hypertension Management and ControlA Systematic Review" available here: https://jamanetwork.com/journals/jama-health-forum/fullarticle/2814987"El susto" available here: https://elsustomovie.com/ -
Welcome to the second episode of Health Econ On The Go. In this episode, we will cover three papers from January 2024, touching on the impact of taxes on the consumption of sugary beverages, types of epidemiological and macroeconomic models and a review of payment reform in the inpatient sector. We launched this podcast with the moto "finish not perfect", so please leave me your comments and questions at [email protected]
Papers discussed on this episode:
“Availability and Coverage of New Drugs in 6 High-Income Countries With Health Technology Assessment Bodies" available here: https://www.sciencedirect.com/science/article/pii/S0168851023002750“Evaluation of changes in price and purchases following implementation of sugar-sweetened beverage taxes across the US" available here: https://jamanetwork.com/journals/jama-health-forum/fullarticle/2813506“A scoping review and taxonomy of epidemiological-macroeconomic models of COVID-19" available here: https://www.valueinhealthjournal.com/article/S1098-3015(23)06154-5/fulltext“The end of an era? Activity-based funding based on diagnostic-related groups: a review of payment reforms in the inpatient sector in 10 high-income countries" available here: https://www.sciencedirect.com/science/article/pii/S0168851023002750 -
Welcome to the first episode of Health Econ On The Go. In this episode, we will cover the top 10 trends for 2024-2025 by ISPOR and two papers from December 2023. The first paper will discuss financing health and care workers in 33 African countries, and the second will discuss a framework for the fair pricing of medicine. I am launching with the moto "finish not perfect", so please leave me your comments and questions at [email protected]
